A randomized, double-blind, placebo-controlled, phase II study to assess the efficacy and safety of oral vismodegib for the treatment of basal cell carcinoma preceding excision by Mohs micrographic surgery
|Effective start/end date
|10/23/13 → 12/31/15
- GENENTECH, INC.
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.